Akari Therapeutics Plc (AKTX)

11.02 +0.87 (+8.57%) USD  |  NASDAQ  |  Sep 03, 16:00
10.70 -0.32 (-2.90%) After-Hours: 20:00
More

Akari Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
argenx SE Upgrade
Autolus Therapeutics Plc Upgrade
Evaxion AS Upgrade